Results 91 to 100 of about 154,404 (310)

Statins [PDF]

Chest, 2014
openaire   +3 more sources

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence ofRhizopus oryzae [PDF]

, 2016
Anne‐Pauline Bellanger, Alexander M. Tatara, Fazal Shirazi, Teclegiorgis Gebremariam, Nathaniel D. Albert, Russell E. Lewis, Ashraf S. Ibrahim, Dimitrios P. Kontoyiannis   +7 more
openalex   +1 more source

BioNTech/Pfizer-Vaccine, Statin Therapy and Self Limiting Rhabdomyolysis

, 2022
J Hacker, M Mohammadzadeh-Vazifeh, B Schoser, Hansen HC   +3 more
openalex   +1 more source

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

Increased Statin Prescribing Does Not Lower Pneumonia Risk [PDF]

, 2015
Linnea A. Polgreen, Elizabeth Cook, John M. Brooks, Yuexin Tang, Philip M. Polgreen   +4 more
openalex   +1 more source

STATINS, BUT NOT PCSK9 INHIBITORS, REDUCE THE ADIPOKINE CHEMERIN IN FAMILIAL HYPERCHOLESTEROLEMIA: FOCUS ON LIPOPROTEIN SUBFRACTIONS

, 2022
Lunbo Tan, Na Wang, Leonie Van Vark Van Der Zee, Jeanine E. Roeters van Lennep, Monique T. Mulder, Xifeng Lu, A.H. Jan Danser, Koen Verdonk   +7 more
openalex   +2 more sources

Fostering medication review competence of pharmacy students: An assessment by students and their preceptors after advanced‐level practical internship

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study was to introduce a new assessment method for pharmacy students' real‐life competence in reviewing medications after obligatory advanced‐level practical internship in Finland. Methods The new medication review (MR) competence assessment method consisted of (1) a self‐assessment by pharmacy students and (2) a performance ...
Katja Leiman, Aleksi Westerholm, Tero Vahlberg, Noora Lias, Tanja Lindholm, Marja Airaksinen   +5 more
wiley   +1 more source

An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy [PDF]

, 2015
Laura Nichols, Kurt Pfeifer, Andrew L. Mammen, Nazima Shahnoor, Chamindra G. Konersman   +4 more
openalex   +1 more source

Personalized statin treatment plan using counterfactual approach with multi-objective optimization over benefits and risks

, 2023
Yue Liang, Pui Ying Yew, Matt Loth, Terrence J Adam, Julian Wolfson, Peter J. Tonellato, Chin-Lin Chi   +6 more
openalex   +1 more source